150 related articles for article (PubMed ID: 33264210)
1. Importance of Reviewing Antibiotic Courses by 48 Hours: Risk Factors for Third-Generation Cephalosporin Resistance Among AmpC Harboring Organisms in Urine and Respiratory Cultures.
Stultz JS; Bice T; Johnstone K; Stuart CM; Shelton CM; Arnold SR; Bagga B; Lee KR
Pediatr Infect Dis J; 2021 May; 40(5):440-445. PubMed ID: 33264210
[TBL] [Abstract][Full Text] [Related]
2. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.
Tamma PD; Girdwood SC; Gopaul R; Tekle T; Roberts AA; Harris AD; Cosgrove SE; Carroll KC
Clin Infect Dis; 2013 Sep; 57(6):781-8. PubMed ID: 23759352
[TBL] [Abstract][Full Text] [Related]
3. Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms.
McKamey L; Venugopalan V; Cherabuddi K; Borgert S; Voils S; Shah K; Klinker KP
Int J Antimicrob Agents; 2018 Nov; 52(5):719-723. PubMed ID: 30125680
[TBL] [Abstract][Full Text] [Related]
4. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use.
Choi SH; Lee JE; Park SJ; Choi SH; Lee SO; Jeong JY; Kim MN; Woo JH; Kim YS
Antimicrob Agents Chemother; 2008 Mar; 52(3):995-1000. PubMed ID: 18086837
[TBL] [Abstract][Full Text] [Related]
5. Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review.
Mizrahi A; Delerue T; Morel H; Le Monnier A; Carbonnelle E; Pilmis B; Zahar JR;
Int J Antimicrob Agents; 2020 Feb; 55(2):105834. PubMed ID: 31682902
[TBL] [Abstract][Full Text] [Related]
6. Leveraging stewardship to promote ceftriaxone use in severe infections with low- and no-risk AmpC Enterobacterales.
Hardy ME; Kenney RM; Tibbetts RJ; Shallal AB; Veve MP
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0082623. PubMed ID: 37882541
[TBL] [Abstract][Full Text] [Related]
7. Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia: an analysis of 249 cases caused by Citrobacter, Enterobacter and Serratia species.
Kim BN; Lee SO; Choi SH; Kim NJ; Woo JH; Ryu J; Kim YS
Int J Antimicrob Agents; 2003 Aug; 22(2):106-11. PubMed ID: 12927949
[TBL] [Abstract][Full Text] [Related]
8. Prior antimicrobial therapy and resistance of Enterobacter Citrobacter and Serratia to third generation cephalosporins.
Nicolle LE
J Hosp Infect; 1988 May; 11(4):321-7. PubMed ID: 2899583
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
Harris PN; Ferguson JK
Int J Antimicrob Agents; 2012 Oct; 40(4):297-305. PubMed ID: 22824371
[TBL] [Abstract][Full Text] [Related]
10. Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
Zerr DM; Miles-Jay A; Kronman MP; Zhou C; Adler AL; Haaland W; Weissman SJ; Elward A; Newland JG; Zaoutis T; Qin X
Antimicrob Agents Chemother; 2016 Jul; 60(7):4237-43. PubMed ID: 27139486
[TBL] [Abstract][Full Text] [Related]
11. Pediatric infection and intestinal carriage due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae.
Zerr DM; Qin X; Oron AP; Adler AL; Wolter DJ; Berry JE; Hoffman L; Weissman SJ
Antimicrob Agents Chemother; 2014 Jul; 58(7):3997-4004. PubMed ID: 24798269
[TBL] [Abstract][Full Text] [Related]
12. Early onset Morganella morganii sepsis in a newborn infant with emergence of cephalosporin resistance caused by depression of AMPC beta-lactamase production.
Sinha AK; Kempley ST; Price E; Sharma BK; Livermore DM
Pediatr Infect Dis J; 2006 Apr; 25(4):376-7. PubMed ID: 16567997
[TBL] [Abstract][Full Text] [Related]
13. A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.
Tamma PD; Doi Y; Bonomo RA; Johnson JK; Simner PJ;
Clin Infect Dis; 2019 Sep; 69(8):1446-1455. PubMed ID: 30838380
[TBL] [Abstract][Full Text] [Related]
14. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
15. Frequency of Multidrug-Resistant Organisms Cultured From Urine of Children Undergoing Clean Intermittent Catheterization.
Forster CS; Courter J; Jackson EC; Mortensen JE; Haslam DB
J Pediatric Infect Dis Soc; 2017 Nov; 6(4):332-338. PubMed ID: 29186590
[TBL] [Abstract][Full Text] [Related]
16. Impact of antibiotic susceptibility reporting on broad spectrum antibiotic use in serratia and morganella bacteremia.
Ng WHW; Chew KL; Yong JHY; Li JX
J Chemother; 2022 Sep; 34(5):311-318. PubMed ID: 35193457
[TBL] [Abstract][Full Text] [Related]
17. The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.
Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Omorogbe J; Dankwa L; Wheeler M; Tolomeo P; Han JH;
BMC Infect Dis; 2019 Feb; 19(1):163. PubMed ID: 30764770
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England.
Potz NA; Hope R; Warner M; Johnson AP; Livermore DM;
J Antimicrob Chemother; 2006 Aug; 58(2):320-6. PubMed ID: 16735428
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
Taneja N; Rao P; Arora J; Dogra A
Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
[TBL] [Abstract][Full Text] [Related]
20. Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut.
Tenover FC; Mohammed MJ; Gorton TS; Dembek ZF
J Clin Microbiol; 1999 Dec; 37(12):4065-70. PubMed ID: 10565933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
